Laila S. Al-Saadi

Dr. Laila S. Al-Saadi

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
RARuhina Aimaq
Ruhina Aimaq
HAHana ALSumri
Hana ALSumri
AMAmal Malehi
Amal Malehi
Zainab Mahmmod Al-ZadjaliZainab Mahmmod Al-Zadjali
Zainab Mahmmod Al-Zadjali
KAKouthar S. Al-Alawi
Kouthar S. Al-Alawi
Moon Fai ChanMoon Fai Chan
Moon Fai Chan
Life expectancy (LE) varies widely across Organization of Islamic Cooperation (OIC) countries, reflecting differences in economic, social, environmental, and health-system conditions. This review aimed to synthesize quantitative evidence on determinants of LE at birth in OIC member countries. The study was conducted in accordance with the PRISMA guidelines, and a systematic search of electronic databases was performed up to September 2025. After screening 5312 records and assessing full texts, studies were appraised using the Joanna Briggs Institute checklists, with an inclusion threshold of ≥80%. A total of 54 studies, mainly ecological, time-series, and panel analyses using national-level data, were included. Higher gross domestic product per capita, education, employment, and health expenditure were consistently associated with longer LE. In contrast, poverty, income inequality, air pollution, and carbon dioxide emissions were associated with shorter LE. Clear differences were observed across World Bank income groups, with LE being lowest in low-income OIC countries and highest in high-income Gulf Cooperation Council states, where gains were driven more by health-system resources than by income growth. Improving LE in OIC countries requires integrated economic, social, environmental, and health-system policies.

1 January 2026 in The Scientific World Journal
Verified
Journal Article
Open access
Zainab Mahmmod Al-ZadjaliZainab Mahmmod Al-Zadjali
Zainab Mahmmod Al-Zadjali
FKFaryal khamis
Faryal khamis
SJSanjay Jaju
Sanjay Jaju
AMAmal Saki Malehi
Amal Saki Malehi
Sulaiman Dawood Al SabeiSulaiman Dawood Al Sabei
Sulaiman Dawood Al Sabei
YAYahya Al-Farsi
Yahya Al-Farsi
Background: Combined antiretroviral therapy (cART) has transformed HIV infection from a life‐threatening condition into a manageable chronic disease by reducing viral replication, preserving immune function, and lowering HIV‐related morbidity and mortality. Nevertheless, achieving and maintaining viral suppression remains an important challenge. Evidence regarding factors associated with nonoptimal virological response among people living with HIV in Oman remains limited. Aim: This study investigated factors associated with nonoptimal virological response among adults living with HIV who initiated cART and received follow‐up at the Royal Hospital, Oman, between 1992 and 2024. Methods: A retrospective cohort study was undertaken at the Royal Hospital, Muscat, Oman, the national tertiary referral center for HIV care. The analysis included 549 adults aged ≥ 18 years who initiated cART and had the laboratory and clinical information required for the study. Participants were eligible if they had two consecutive HIV RNA measurements, both obtained at least 6 months after cART initiation. Optimal viral suppression was defined as HIV RNA ≤ 20 copies/mL, whereas nonoptimal virological response was classified only when both consecutive HIV RNA measurements were > 20 copies/mL, based on the laboratory and clinical monitoring threshold used at the Royal Hospital and Ministry of Health guidance. Participants with only one eligible measurement or discordant measurements were not classified as having a nonoptimal virological response. Clinical information was retrospectively retrieved from electronic medical records. Data were analyzed using IBM SPSS Statistics Version 28. Multivariable Poisson regression with robust variance was used to estimate adjusted risk ratios (aRRs) and corresponding 95% confidence intervals (CIs). Statistical significance was considered at p ≤ 0.05. Results: Of the 549 participants, 321 (58.5%) had HIV RNA ≤ 20 copies/mL and 228 (41.5%) had HIV RNA > 20 copies/mL. Compared with individuals diagnosed in 2020 or later, the risk of nonoptimal virological response was higher among those diagnosed in 2008 or earlier (aRR: 2.166, 95% CI: 1.160–4.043) and those diagnosed between 2009 and 2014 (aRR: 2.273, 95% CI: 1.258–4.107). Male participants had a higher risk than female (aRR: 2.154, 95% CI: 1.172–3.960). Diagnosis through antenatal care was also associated with nonoptimal virological response (aRR: 3.662, 95% CI: 1.263–10.618), although the estimate should be interpreted cautiously because of the small number of participants in this category. WHO clinical Stage 3 was associated with a lower estimated risk compared with Stage 4, although the association was not statistically significant (aRR: 0.592, 95% CI: 0.349–1.005; p = 0.052). Participants with hemoglobin levels ≤ 10 g/dL also had an increased risk of nonoptimal virological response (aRR: 1.676, 95% CI: 1.020–2.753). Conclusion: Five sociodemographic and clinical factors were independently associated with detectable HIV RNA among adults receiving cART in Oman: sex, period of HIV diagnosis, antenatal testing, WHO clinical stage, and hemoglobin concentration. These findings support continued efforts to identify patients who may require closer clinical monitoring and individualized support to achieve and maintain viral suppression.